Review
Psychiatry
J. Vaquerizo-Serrano, G. Salazar De Pablo, J. Singh, P. Santosh
Summary: Catatonic features can appear in individuals with autism spectrum disorders (ASDs), affecting around 10.4% of ASD patients, commonly males. Treatment options include benzodiazepines, antipsychotics, and electroconvulsive therapy (ECT) with promising results in managing catatonic symptoms. Longitudinal studies are needed to further understand the relationship between catatonia and ASD.
EUROPEAN PSYCHIATRY
(2021)
Article
Clinical Neurology
Adrienne Clermont, Daphne Loubriel, Erin Li, Darlene Mitera, Susan Samuels
Summary: This case highlights the importance of prompt diagnosis and treatment of catatonia in adolescent patients, as well as the safety and efficacy of ECT in this population.
Article
Psychiatry
Liliana Dell'Osso, Giulia Amatori, Barbara Carpita, Gabriele Massimetti, Benedetta Nardi, Davide Gravina, Francesca Benedetti, Chiara Bonelli, Danila Casagrande, Mario Luciano, Isabella Berardelli, Natascia Brondino, Marianna De Gregorio, Giacomo Deste, Marta Nola, Antonino Reitano, Maria Rosaria Anna Muscatello, Maurizio Pompili, Pierluigi Politi, Antonio Vita, Mario Maj
Summary: Several studies have found a correlation between autism spectrum disorder (ASD) and catatonia, both of which are also associated with mood disorders. This study aimed to investigate the relationship between autistic traits and catatonic symptoms, as well as the potential mediating role of mood disorder spectrum. The results showed strong positive correlations, with the strongest coefficient observed between AdAS Spectrum total score and CS total score. Mediation analysis revealed that the mood disorder spectrum had a significant indirect effect on the relationship between autistic traits and catatonic symptoms.
FRONTIERS IN PSYCHIATRY
(2023)
Article
Psychiatry
Toshinori Nakamura, Misaki Shimizu-Ichikawa, Kazuhito Takahashi, Sari Shimizu, Takashi Ichiyama, Keisuke Todoroki, Masataka Konno, Daisuke Amada, Daimei Sasayama, Shinsuke Washizuka
Summary: This article describes a case of sudden respiratory failure during the treatment of catatonia, which required intensive care. Electroconvulsive therapy (ECT) was successfully administered in the intensive care unit, relieving the catatonia symptoms and improving the respiratory failure. It highlights the importance of monitoring the patient's physical and psychological symptoms, as respiratory status may deteriorate rapidly in a catatonic state.
ASIAN JOURNAL OF PSYCHIATRY
(2022)
Article
Psychiatry
Kasturi Atmaram Sakhardande, Harsh Pathak, Jayant Mahadevan, Krishna Prasad Muliyala, Sydney Moirangthem, Venkata Senthil Kumar Reddi
Summary: Catatonia is a neuropsychiatric manifestation associated with COVID-19 infection. Management of catatonia in COVID-19 infection remains a clinical challenge, with limited information on the safety and efficacy of benzodiazepines and Electro-convulsive therapy (ECT). This study presents the experience of managing five patients with catatonia and COVID-19 infection, highlighting the varying underlying causes for catatonia and the potential role of COVID-19 in its manifestation. The study suggests that new-onset catatonia in COVID-19 patients can be effectively managed with lorazepam and/or ECT, with the need for modified protocols integrating pre-emptive evaluation for COVID-19 and proactive monitoring of relevant clinical parameters.
ASIAN JOURNAL OF PSYCHIATRY
(2022)
Article
Psychiatry
Neera Ghaziuddin, Tareq Yaqub, Wael Shamseddeen, Priyanka Reddy, Hannah Reynard, Daniel Maixner
Summary: The study aimed to investigate the naturalistic clinical course in adolescent and young adult patients with developmental delays and catatonia, when maintenance electroconvulsive therapy (M-ECT) frequency was reduced due to COVID-19 restrictions. Participants showed significant decline in symptoms, particularly motor symptoms, leading to rehospitalization for some patients.
FRONTIERS IN PSYCHIATRY
(2021)
Article
Psychiatry
Nicholas Bonomo, Haojiang Huang, Ben Schoenbachler
Summary: Catatonia is a complicated condition associated with various psychiatric and medical conditions. The standard treatment involves managing the underlying primary condition and using benzodiazepines or electroconvulsive therapy. However, some patients do not tolerate or have access to these treatments, leading to the exploration of alternative options such as Z drugs. In this case report, the patient with post-traumatic stress disorder and secondary psychotic features showed a positive response to scheduled zolpidem, suggesting that Z drugs may be preferable to benzodiazepines in managing catatonia in similar populations.
Article
Psychiatry
Aaron J. Hauptman, David Cohen, Dirk Dhossche, Marie Raffin, Lee Wachtel, Vladimir Ferrafiat
Summary: Despite the inclusion of catatonia as a specifier of autism spectrum disorder in DSM-5, we have identified issues with the diagnosis and clinical management of catatonia in neurodevelopmental disorders. In this Personal View, we summarize the literature, describe our concerns, and offer a novel approach to addressing these issues. We propose a measure considering previous symptoms and suggest two concepts for understanding catatonia. We hope this measure will benefit clinicians and researchers working with this underserved population.
Article
Clinical Neurology
Kamber L. Hart, Michael E. Henry, Thomas H. Mccoy, Stephen J. Seiner, James Luccarelli
Summary: This study investigates the correlation between response to electroconvulsive therapy (ECT) in different treatment courses. The findings suggest that while the overall final depression symptom scores were similar, there was no correlation between the change in symptoms for individual patients between treatment series. Further research is needed to predict longitudinal ECT response.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Article
Clinical Neurology
Kamber L. Hart, Thomas H. McCoy Jr, Michael E. Henry, Stephen J. Seiner, James Luccarelli
Summary: This study quantified the frequency and type of residual symptoms following electroconvulsive therapy (ECT) and found high rates of residual symptoms among patients with depression receiving ECT treatment.
JOURNAL OF AFFECTIVE DISORDERS
(2023)
Review
Clinical Neurology
Akihiro Takamiya, Morinobu Seki, Shun Kudo, Takahito Yoshizaki, Jin Nakahara, Masaru Mimura, Taishiro Kishimoto
Summary: The study reviewed previous clinical studies and found that ECT is effective in improving both motor and non-motor symptoms in patients with Parkinson's disease, especially in those without psychiatric symptoms. ECT also significantly improved depression, psychosis, wearing-off phenomenon, without worsening cognitive functioning.
MOVEMENT DISORDERS
(2021)
Article
Clinical Neurology
Kamber L. Hart, Michael E. Henry, Thomas H. Mccoy, Stephen J. Seiner, James Luccarelli
Summary: This study found no correlation between response to electroconvulsive therapy (ECT) in two independent treatment courses for individual patients. This suggests that the response to ECT may be influenced by individual-specific factors that need to be further investigated.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Article
Pediatrics
Joshua Ryan Smith, Tasia York, Samuel Warn, Darara Borodge, Donald L. Pierce, D. Catherine Fuchs
Summary: Individuals with profound autism often present for inpatient care due to aggression. Agitated catatonia is a treatable comorbidity in autism, which should be considered in cases of aggression. Preliminary data report high clinical response rates of catatonia in autism when treated with electroconvulsive therapy (ECT), with poor response to lorazepam. However, access to ECT is often limited, especially in pediatric populations.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
(2023)
Article
Psychiatry
Maximilian Cronemeyer, Carlos Schoenfeldt-Lecuona, Maximilian Gahr, Ferdinand Keller, Alexander Sartorius
Summary: This study compared the effectiveness of different MC treatment approaches and found that combining benzodiazepines and electroconvulsive therapy (ECT) had the most favorable outcomes, with early initiation of benzodiazepines being associated with favorable outcomes. Patients with severe MC were more likely to receive intensive care treatment and had a higher risk of death compared to those with moderate MC.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
(2022)
Article
Psychiatry
Yan Yang, Di Kong, Qiwen Li, Wei Chen, Guocheng Zhao, Xi Tan, Xincheng Huang, Zipeng Zhang, Can Feng, Min Xu, Ying Wan, Mi Yang
Summary: This study found that non-antipsychotic medicines and modified electroconvulsive therapy (MECT) were risk factors for hospital-acquired pneumonia (HAP) in schizophrenia patients treated with antipsychotics.
FRONTIERS IN PSYCHIATRY
(2023)
